{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:42:05Z","timestamp":1792122125278,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008875","name":"Shanghai Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008875","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.yjmcc.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T11:14:29Z","timestamp":1562757269000},"page":"107-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The lymphocyte adapter protein: A negative regulator of myocardial ischemia\/reperfusion injury"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-4422","authenticated-orcid":false,"given":"Jia","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genshan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yjmcc.2019.07.003_bb0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/heartjnl-2015-307855","article-title":"Reducing myocardial infarct size: challenges and future opportunities","volume":"102","author":"Bulluck","year":"2016","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.yjmcc.2019.07.003_bb0010","first-page":"774","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge","volume":"38","author":"Heusch","year":"2017","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.07.003_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"23","key":"10.1016\/j.yjmcc.2019.07.003_bb0020","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/eurheartj\/eht090","article-title":"Myocardial reperfusion injury: looking beyond primary PCI","volume":"34","author":"Frohlich","year":"2013","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.07.003_bb0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2019.07.003_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/iub.1180","article-title":"Cell death in the myocardium: my heart won't go on","volume":"65","author":"Orogo","year":"2013","journal-title":"IUBMB Life"},{"issue":"10","key":"10.1016\/j.yjmcc.2019.07.003_bb0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.2042-7158.1991.tb03471.x","article-title":"Gastrointestinal absorption of quaternary ammonium compounds correlated to their binding to small intestinal brush border membrane in rat","volume":"43","author":"Saitoh","year":"1991","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.07.003_bb0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbrc.2004.01.060","article-title":"Roles of a conserved family of adaptor proteins, Lnk, SH2-B, and APS, for mast cell development, growth, and functions: APS-deficiency causes augmented degranulation and reduced actin assembly","volume":"315","author":"Kubo-Akashi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.yjmcc.2019.07.003_bb0045","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bcp.2011.06.023","article-title":"The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling","volume":"82","author":"Devalliere","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.07.003_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ng.384","article-title":"Genome-wide association study of blood pressure and hypertension","volume":"41","author":"Levy","year":"2009","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.07.003_bb0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/ng.323","article-title":"Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction","volume":"41","author":"Gudbjartsson","year":"2009","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.07.003_bb0060","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/HYPERTENSIONAHA.114.04736","article-title":"Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation","volume":"65","author":"Rudemiller","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.yjmcc.2019.07.003_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2009.03.019","article-title":"Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway?","volume":"47","author":"Lecour","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.07.003_bb0070","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00395-011-0210-z","article-title":"RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning","volume":"106","author":"Tamareille","year":"2011","journal-title":"Basic Res. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.07.003_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00395-013-0351-3","article-title":"Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection","volume":"108","author":"Sanchez","year":"2013","journal-title":"Basic Res. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.07.003_bb0080","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1096\/fj.11-193383","article-title":"LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets alpha-parvin to control cell adhesion and migration","volume":"26","author":"Devalliere","year":"2012","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.yjmcc.2019.07.003_bb0085","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCRESAHA.108.192856","article-title":"Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration","volume":"104","author":"Kwon","year":"2009","journal-title":"Circ. Res."},{"issue":"29","key":"10.1016\/j.yjmcc.2019.07.003_bb0090","doi-asserted-by":"crossref","first-page":"20148","DOI":"10.1074\/jbc.M510997200","article-title":"The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways","volume":"281","author":"Fitau","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.07.003_bb0095","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1189\/jlb.0309185","article-title":"Adaptor protein Lnk inhibits c-Fms-mediated macrophage function","volume":"88","author":"Gueller","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.07.003_bb0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0002-9149(00)01062-6","article-title":"Clinical and neurohormonal correlates of circulating granulocyte-macrophage colony-stimulating factor in severe heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"86","author":"Parissis","year":"2000","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.07.003_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2010.05.002","article-title":"TNFalpha in atherosclerosis, myocardial ischemia\/reperfusion and heart failure","volume":"127","author":"Kleinbongard","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.yjmcc.2019.07.003_bb0110","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.110.226936","article-title":"The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls","volume":"108","author":"Mann","year":"2011","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.07.003_bb0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.2354","article-title":"GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice","volume":"17","author":"Kempf","year":"2011","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.07.003_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nri3800","article-title":"Role of innate and adaptive immune mechanisms in cardiac injury and repair","volume":"15","author":"Epelman","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.07.003_bb0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.170.2.703","article-title":"Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein","volume":"170","author":"Takaki","year":"2003","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.07.003_bb0130","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1172\/JCI81468","article-title":"LNK\/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors","volume":"126","author":"Cheng","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.07.003_bb0135","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ajhg.2010.05.004","article-title":"Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection","volume":"86","author":"Zhernakova","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.07.003_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/CS20140444","article-title":"Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse","volume":"129","author":"Parapanov","year":"2015","journal-title":"Clin. Sci."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.07.003_bb0145","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCRESAHA.113.300765","article-title":"Cardioprotection and myocardial reperfusion: pitfalls to clinical application","volume":"113","author":"Vander Heide","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.07.003_bb0150","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/j.2040-4603.2015.tb00650.x","article-title":"Treatment of myocardial ischemia\/reperfusion injury by ischemic and pharmacological postconditioning","volume":"5","author":"Heusch","year":"2015","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.07.003_bb0155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.07.003_bb0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3089.2011.00629.x","article-title":"Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection","volume":"18","author":"Chatelais","year":"2011","journal-title":"Xenotransplantation"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818309465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818309465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:28:27Z","timestamp":1758313707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818309465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":32,"alternative-id":["S0022282818309465"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.07.003","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The lymphocyte adapter protein: A negative regulator of myocardial ischemia\/reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}